Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Hayer

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Arthritis and Rheumatism|January 1, 2008
Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophyKlaus Bobacz, Ilse-Gerlinde Sunk, Silvia Hayer, et al.
Bone & Joint Research|July 8, 2022
Analysis of combined deficiency of interleukin-1 and -6 versus single deficiencies in TNF-mediated arthritis and systemic bone lossSilvia Hayer, Birgit Niederreiter, Marlene Kalkgruber, et al.
Arthritis and Rheumatism|January 3, 2013
Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritisNikolaus B Binder, Antonia Puchner, Birgit Niederreiter, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Vitamin D receptor regulates TNF-mediated arthritisKarin Zwerina, Wolfgang Baum, Roland Axmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2005
Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorptionJochen Zwerina, Sotiria Tzima, Silvia Hayer, et al.
Arthritis and Rheumatism|July 13, 2004
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritisPetra Herrak, Birgit Görtz, Silvia Hayer, et al.
Arthritis Research & Therapy|January 12, 2005
JNK1 is not essential for TNF-mediated joint diseaseMarcus Köller, Silvia Hayer, Kurt Redlich, et al.
Arthritis and Rheumatism|January 20, 2004
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destructionJochen Zwerina, Silvia Hayer, Makiyeh Tohidast-Akrad, et al.
The American Journal of Pathology|January 27, 2004
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritisKurt Redlich, Birgit Görtz, Silvia Hayer, et al.
Arthritis and Rheumatism|February 16, 2011
Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in miceStephan Blüml, Michael Bonelli, Birgit Niederreiter, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Arthritis and Rheumatism|January 1, 2008
Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophyKlaus Bobacz, Ilse-Gerlinde Sunk, Silvia Hayer, et al.
Bone & Joint Research|July 8, 2022
Analysis of combined deficiency of interleukin-1 and -6 versus single deficiencies in TNF-mediated arthritis and systemic bone lossSilvia Hayer, Birgit Niederreiter, Marlene Kalkgruber, et al.
Arthritis and Rheumatism|January 3, 2013
Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritisNikolaus B Binder, Antonia Puchner, Birgit Niederreiter, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Vitamin D receptor regulates TNF-mediated arthritisKarin Zwerina, Wolfgang Baum, Roland Axmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2005
Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorptionJochen Zwerina, Sotiria Tzima, Silvia Hayer, et al.
Arthritis and Rheumatism|July 13, 2004
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritisPetra Herrak, Birgit Görtz, Silvia Hayer, et al.
Arthritis Research & Therapy|January 12, 2005
JNK1 is not essential for TNF-mediated joint diseaseMarcus Köller, Silvia Hayer, Kurt Redlich, et al.
Arthritis and Rheumatism|January 20, 2004
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destructionJochen Zwerina, Silvia Hayer, Makiyeh Tohidast-Akrad, et al.
The American Journal of Pathology|January 27, 2004
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritisKurt Redlich, Birgit Görtz, Silvia Hayer, et al.
Arthritis and Rheumatism|February 16, 2011
Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in miceStephan Blüml, Michael Bonelli, Birgit Niederreiter, et al.
Pageof 5